In Silico Testing of an Artificial-Intelligence-Based Artificial Pancreas Designed for Use in the Intensive Care Unit Setting
Conclusions:
This in silico study of an AI-based closed loop glucose controller shows that it may be able to improve on the results achieved by currently existing ICU-based PID/MPC controllers. If these results are confirmed in clinical testing, this AI-based controller could be used to create an artificial pancreas system for use in the ICU setting.
Source: Journal of Diabetes Science and Technology - Category: Endocrinology Authors: DeJournett, L., DeJournett, J. Tags: Original Articles Source Type: research
More News: Diabetes | Endocrinology | Health Management | Insulin | Intensive Care | Pancreas | Science | Study